SGX Nifty signifies Indian Nifty in Singapore Stock Exchange. NSE defines the characteristics of the futures contract such as the underlying security, market lot, and maturity date of the contract. P = price of a put option US market impacts SGX Nifty movements during US market hours. SGX CNX Nifty Index May '23 Futures Price - Barchart.com :We acknowledge our awareness of the use of our report dated November 21,2022 related to our review of interim financial information includedwithin the Quarterly Report on Form 10-Q of The Home Depot,Inc.for the three-month and nine-month periods ended October 30,2022,andincorporated by reference in the following Registration Statements:DescriptionRegistrationStatement NumberForm S-3Depot Direct stock purchase program333-249732Debt securities333-259121Form S-8The Home Depot,Inc.1997 Omnibus Stock Incentive Plan333-61733The Home Depot Canada Registered Retirement Savings Plan333-38946The Home Depot,Inc.Restated and Amended Employee Stock Purchase Plan333-151849The Home Depot,Inc.Amended and Restated Employee Stock Purchase Plan333-182374The Home Depot,Inc.Non-Qualified Stock Option and Deferred Stock Units Plan and Agreement333-56722The Home Depot,Inc.2005 Omnibus Stock Incentive Plan333-125331The Home Depot,Inc.2005 Omnibus Stock Incentive Plan333-153171The Home Depot FutureBuilder and The Home Depot FutureBuilder for Puerto Rico333-125332Pursuant to Rule 436 under the Securities Act of 1933(the Act),such report is not considered part of a registration statement prepared orcertified by an independent registered public accounting firm,or a report prepared or certified by an independent registered public accountingfirm within the meaning of Sections 7 and 11 of the Act./s/KPMG LLPAtlanta,GeorgiaNovember 21,2022Exhibit 31.1CERTIFICATIONI,Edward P.Decker,certify that:1.I have reviewed this quarterly report on Form 10-Q of The Home Depot,Inc. Markets reversed early losses to close higher, snapping a two-day losing streak. 2) NSE Nifty 50 is considered the most important broad market index for Indian markets, 3) SGX Nifty tracks the movement of Nifty and is available to trade for much longer hours. WebSGX Options chart. If it falls on a Taiwan public holiday, the Last Trading Day will be the preceding trading day which is also a business day in Taiwan. Varun Aggarwal on LinkedIn: In a major development for Indian C = S * N (d1) - X * e- rt* N (d2), and the price for a Put is : P = X * e- rt* N (-d2) - S * N (-d1), where : SGX 8:45 am-1:45 pm (T); 2:30 pm-3:00 am (T+1), The average of the underlying Index values on the LTD taken at (i) 1-minute intervals during the last 25 minutes of trading on the Taiwan Stock Exchange Corporation before the end of the continuous trading session, and (ii) the closing index value, rounded to the nearest 2 decimal places. Contract Specifications Investor education on how to invest safely and protect your investments. Apart from India the exchange also allows one to take positions in FTSE, China A50 index, MSCI Asia, MSCI Hongkong, MSCI Singapore, MSCI Taiwan ,Nikkei 225, Strait Times etc. The second last trading day of the contract month. (theCompany)on Form 10-Q(Form 10-Q)for the period ended October 30,2022 as filed with the Securities and Exchange Commission,I,Edward P.Decker,Chair,President and Chief Executive Officer of the Company,certify,pursuant to 18 U.S.C.Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,that,to my knowledge:(1)The Form 10-Q fully complies with the requirements of section 13(a)or 15(d)of the Securities Exchange Act of 1934;and(2)The information contained in the Form 10-Q fairly presents,in all material respects,the financial condition and results of operations ofthe Company./s/Edward P.DeckerEdward P.DeckerChair,President and Chief Executive OfficerNovember 21,2022Exhibit 32.2CERTIFICATION PURSUANT TO18 U.S.C.SECTION 1350AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002In connection with the Quarterly Report of The Home Depot,Inc. SGX NIFTY (2)Average ticket represents the average price paid per transaction and is used by management to monitor the performance of the Company,as it represents aprimary driver in measuring sales performance. (Registrant)By:/s/EDWARD P.DECKEREdward P.Decker,Chair,President and Chief Executive Officer(Principal Executive Officer)/s/RICHARD V.MCPHAILRichard V.McPhail,Executive Vice President and Chief FinancialOfficer(Principal Financial Officer)/s/STEPHEN L.GIBBSStephen L.Gibbs,Vice President,Chief Accounting Officer andCorporate Controller(Principal Accounting Officer)Date:November 21,202223Exhibit 15.1ACKNOWLEDGEMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMTo the Stockholders and Board of DirectorsThe Home Depot,Inc. The base price of futures contracts on the first day of trading (i.e. WebSGX INDIA SINGLE STOCK FUTURES CONTRACT SPECIFICATIONS 1. *In a few cases,though the policies do not directly mention about a particular incentive,an indication of indirect initiatives has been consideredSource:Respective state government websites;Invest India website updated as of November 2022;CBRE Research,Q1 2023State-level Policies are Additional Investment MagnetsFigure 3.2:Key state-level policies for the LS sector in India 11)%Haryana Pharmaceutical Policy,2019Uttar Pradesh Pharmaceutical Industry Policy,2018Rajasthan MedTech and Bulk Drug Policy,2021Karnataka Biotechnology Policy,2017Gujarat Biotechnology Policy,2022 Telangana Life Sciences Policy,2015Odisha Biotechnology Policy,2018Tamil Nadu Life Sciences Policy,202211289647352Himachal PradeshMadhya PradeshMaharashtraAndhra PradeshLEGENDLand-related incentivesInfrastructure developmentCapital subsidies/capital interest subsidiesStamp duty exemptionsTax benefitsSingle-window clearance/ease of approvalsStates with dedicated LS policiesExisting medical devices clusters3 Bulk Drug Parks proposedHimachal Pradesh,Gujarat and Andhra Pradesh4 Medical Devices Parks proposed Tamil Nadu,Madhya Pradesh,Uttar Pradesh,Himachal PradeshPRIMARY LOCATIONS 1.Hyderabad2.BangaloreSECONDARY LOCATIONS 1.Mumbai2.Pune3.Delhi-NCR4.Chennai5.Ahmedabad6.Vadodara7.Visakhapatnam8.Valsad9.Ankleshwar11 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentChapter 4LS Real Estate Clusters in India12 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentLS company portfolios typically consist of four major components,namely R&D laboratories,logistics facilities(including cold storage),manufacturing facilities and corporate offices,as detailed below:Key Components of LS Real Estate PortfoliosBiotechnology R&DGenetic engineeringCell engineeringEnzyme engineeringFermentation engineeringProtein engineeringRaw materialsPlasmaCell culture geneAntibodies and enzymesLow serum medium AntigenBiomedical manufacturingGenetically engineered drugVaccinesBlood productsDiagnostic reagentLogistics and salesDistributors/3PL playersLogisticsWholesalersConsumersR&D labsResearch organisationsPharmaceutical companiesPharmaceutical companiesUniversitiesHospitalsDistributors/3PL firmsPharmacies/Retail shopsOficesLS parksSmall-sized manufacturing plantsLarge-sized manufacturing plantsOficesLS parksPharmaceutical companiesPharmaceutical companiesResearch organisationsLS parksOficesLS parksIndustrial parksIndustrial parksOther chemical raw materialsCold ChainLogisticsIndustrial parksSource:CBRE Research,Q1 2023Real estate asset types that house LS companies:Components of LS company portfolios:LS parkIndustrial parkOfficeRetailR&D laboratoriesLogistics facilitiesLarge-sized manufacturing plantsSmall-sized manufacturing plants13 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentPharmaceuticals is a highly regulated industry and entails numerous regulatory approvals,including the registration of manufacturing plants and Good Manufacturing Practices(GMP)certifications.An analysis of the WHO-GMP*certified pharmaceutical manufacturing plants in the country revealed that as of 2019,Gujarat housed the highest number of WHO-GMP certified pharma manufacturing plants followed by Maharashtra,Himachal Pradesh and Telangana.Further,Uttarakhand,Tamil Nadu,Karnataka and Andhra Pradesh are also major manufacturing hubs(refer Figure 4.1).Moreover,India ranks second globally in terms of the number of US FDA-certified plants located outside the US,closely following China(refer Figure 4.2).LS Manufacturing Well Supported by Pharmaceutical Clusters in IndiaFigure 4.1:Geographical distribution of WHO-GMP-certified plants in India(as of 2019)Figure 4.2:Percentage of US FDA-certified plants located outside the US(as of May 2022)HimachalPradeshUttarakhandMaharashtraTelanganaAndhraPradeshTamil NaduKarnatakaGujaratLowestHighest19%8%5%5%4%4%4%3%3%3%2%2%2%Source:Central Drugs Standard Control Organization(CDSCO),2019;CBRE Research,Q1 2023*World Health Organization Good Manufacturing PracticesSource:US Food&Drug Administration,May 2022;CBRE Research,Q1 2023ChinaIndiaSouth KoreaCanadaFranceGermanyItalyMexicoUnited KingdomJapanSpainSwitzerlandIrelandTaiwanOthers14 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentTelangana leads with the highest number of US FDA-certified plants,followed by Maharashtra,Gujarat,Andhra Pradesh,Karnataka and Tamil Nadu.Other states with a sizeable presence include Madhya Pradesh and Himachal Pradesh.A further analysis of the type of operations revealed that while Gujarat is the topmost state for general manufacturing,Telangana is the leading state for analysis and API manufacturing.Telangana,Maharashtra and Gujarat are the Key Export ClustersFig 4.3:Distribution of US-FDA certified plants in India(as of May 2022)Fig 4.4:Distribution of US-FDA certified plants by type of operations(as of May 2022)HimachalPradeshMaharashtraTelanganaAndhraPradeshTamil NaduKarnatakaGujaratLowestHighestMadhya PradeshSource:US Food&Drug Administration,May 2022;CBRE Research,Q1 2023*indicates production of finished pharmaceutical products *indicates production of an active ingredient in any pharmaceutical productSource:US Food&Drug Administration,May 2022;CBRE Research,Q1 2023GujaratMaharashtraTelanganaKarnatakaOthersTelanganaAndhra PradeshMaharashtraKarnatakaOthers22%8%#%Manufacturing*API Manufacturing*15 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentIndia has about nine biotechnology clusters at various stages of development,located in Karnataka,Telangana,Tamil Nadu,Gujarat,Uttar Pradesh,Kerala,Chhattisgarh and Jammu&Kashmir.Below is a snapshot of select biotechnology clusters in the country along with an indication of the availability of real estate facilities such as office spaces,manufacturing units,R&D lab spaces and logistics&cold storage facilities.Source:Department of Biotechnology,GoI;CBRE Research,Q1 2023*PPP Public Private Partnership;*for R&D lab space LS Parks Facilitate Office,Manufacturing,R&D and Logistics RequirementsFigure 4.5:Key LS Parks in India11)%CityLucknowLS clusterBiotech Park,LucknowYear of setup2002CategoryEstablished clusterOwnershipGovernmentCityVadodaraLS clusterSavli Biotech ParkYear of setup2007CategoryEstablished clusterOwnershipGovernmentCityChennaiLS clusterTICEL Bio ParkYear of setup2004CategoryEstablished clusterOwnershipGovernmentCityBangaloreLS clusterBengaluru LS ParkYear of setup2022CategoryEmerging clusterOwnershipA PPP*between the Government of Karnataka and private entity Labzone CorporationOther key clustersSyngene Park,BIOCON CampusCityHyderabadLS clusterGenome ValleyYear of setup1999CategoryEstablished clusterOwnershipGovernment land allotments to various private companiesOther key clustersMedical Device Park at Sultanpur,Hyderabad Pharma CityUttar PradeshTamil NaduTelanganaKarnatakaGujaratOffice spacePrimary marketsSecondary marketsManufacturing unitsR&D lab spaceLogistics&cold storage facilities16 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentLeading LS companies in India prefer to operate from large-scale parks that can meet both their office and R&D needs.Startups and MSMEs are also increasingly opting to locate themselves in parks with a clear industrial positioning and abundant R&D resources.Thus,site selection plays an important role for the successful functioning of any LS park catering to various occupier requirements.What do Occupiers Look for in LS Parks?Figure 4.6:Site selection strategy for LS clustersHigh industry concentrationPresence of upstream and downstream industriesHigh quality clinical resources and laboratoriesSupportive central&state policiesPromotion of industrial clustersTransport:Last-mile connectivity,shuttle services,public transportation and parking spacesEnvironment:Green/open spaces and amenitiesCore:Ofice spaces and R&D labsOthers:Exhibition centres,conference rooms,leisure spacesIndustrial land with environmental clearances and a non-contentious titleCompliance with general requirements and building technical codes for biosafe laboratoriesDedicated space for biohazard disposal solutionsSingle storey factory with cleanroomStrict security to prevent theft or leakage of R&D data5.0 m floor height(including space for R&D equipment installation)Electrical Supply:200-650 W/sq.m.Floor Loading:500 1,500 kg/sq.m.Ceiling Bearing:to accommodate air handling unit(AHU)LocationPolicyAmenitiesFunctionLand TitleProperty TypeSpecifications*Note Specifications can vary basis the type of facility(drug substance/drug product/an Oral Solid Dosage(OSD)facility)Source:CBREs Shanghai Pharmaceutical&LS Industry Report,2021;CBRE Research,Q1 202317 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentChapter 5LS Real Estate Trends in India18 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentSustained Leasing Activity by LS Firms over the Last Two Years;Healthcare Companies a Key DriverFigure 6.1:Annual space take-up by LS companies(2019-2022)Rank indicates the LS sector position in overall pan-India leasing as compared to other sectorsFigure 6.2:Sub-sector-wise leasing by LS companies(2019-2022)0%1%2%3%4%5%6%7%0.00.51.01.52.02.53.020192020Rank 8Rank 7Rank 6Rank 620212022(%share)(in million sq.ft.